These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 35538438

  • 1. Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study.
    Jäger C, Stampf S, Molyneux K, Barratt J, Golshayan D, Hadaya K, Huynh-Do U, Binet FI, Mueller TF, Koller M, Kim MJ.
    BMC Nephrol; 2022 May 10; 23(1):178. PubMed ID: 35538438
    [Abstract] [Full Text] [Related]

  • 2. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
    Berthoux F, Suzuki H, Mohey H, Maillard N, Mariat C, Novak J, Julian BA.
    J Am Soc Nephrol; 2017 Jun 10; 28(6):1943-1950. PubMed ID: 28255003
    [Abstract] [Full Text] [Related]

  • 3. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
    Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS.
    Transplant Proc; 2017 Apr 10; 49(3):541-545. PubMed ID: 28340830
    [Abstract] [Full Text] [Related]

  • 4. Serum galactose-deficient immunoglobulin A1 in recurrent immunoglobulin a nephropathy after kidney transplantation: A meta-analysis.
    Gong Z, Tang J, Hu W, Song X, Liu X, Mu J, Su Y.
    Transpl Immunol; 2023 Aug 10; 79():101850. PubMed ID: 37182720
    [Abstract] [Full Text] [Related]

  • 5. Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
    Kawabe M, Yamamoto I, Yamakawa T, Katsumata H, Isaka N, Katsuma A, Nakada Y, Kobayashi A, Koike K, Ueda H, Tanno Y, Koike Y, Miki J, Yamada H, Kimura T, Ohkido I, Tsuboi N, Yamamoto H, Kojima H, Yokoo T.
    Front Immunol; 2020 Aug 10; 11():2068. PubMed ID: 33013875
    [Abstract] [Full Text] [Related]

  • 6. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct 10; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 7. Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation.
    Kawabe M, Yamamoto I.
    Nephron; 2023 Oct 10; 147 Suppl 1():9-13. PubMed ID: 36966530
    [Abstract] [Full Text] [Related]

  • 8. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    Garnier AS, Duveau A, Demiselle J, Croué A, Subra JF, Sayegh J, Augusto JF.
    PLoS One; 2018 Oct 10; 13(4):e0196101. PubMed ID: 29694420
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
    Sofue T, Suzuki H, Ueda N, Kushida Y, Minamino T.
    Nephrology (Carlton); 2018 Jul 10; 23 Suppl 2():4-9. PubMed ID: 29968406
    [Abstract] [Full Text] [Related]

  • 10. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 11. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Jan 11; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 12. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.
    Clin Nephrol; 2001 Oct 11; 56(4):279-88. PubMed ID: 11680657
    [Abstract] [Full Text] [Related]

  • 13. Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
    Kim MJ, Schaub S, Molyneux K, Koller MT, Stampf S, Barratt J.
    PLoS One; 2016 Oct 11; 11(12):e0166830. PubMed ID: 27930655
    [Abstract] [Full Text] [Related]

  • 14. Single-center long-term results of renal transplantation for IgA nephropathy.
    Bumgardner GL, Amend WC, Ascher NL, Vincenti FG.
    Transplantation; 1998 Apr 27; 65(8):1053-60. PubMed ID: 9583865
    [Abstract] [Full Text] [Related]

  • 15. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Apr 27; 41(3):311-320. PubMed ID: 33741175
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients.
    Park WY, Kim Y, Paek JH, Jin K, Han S.
    Kidney Res Clin Pract; 2021 Jun 27; 40(2):317-324. PubMed ID: 33866766
    [Abstract] [Full Text] [Related]

  • 17. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P.
    Nephrol Dial Transplant; 2013 May 27; 28(5):1305-14. PubMed ID: 23229925
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y, Oka K, Moriyama T, Ichimaru N, Kyo M, Kokado Y, Ito T, Imai E, Aozasa K, Okuyama A, Takahara S.
    Transplant Proc; 2004 Jun 27; 36(5):1314-6. PubMed ID: 15251321
    [Abstract] [Full Text] [Related]

  • 19. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
    Sawada A, Kawanishi K, Horita S, Koike J, Honda K, Ochi A, Komoda M, Tanaka Y, Unagami K, Okumi M, Shimizu T, Ishida H, Tanabe K, Nagashima Y, Nitta K.
    Nephrology (Carlton); 2016 Jul 27; 21 Suppl 1():48-52. PubMed ID: 26971743
    [Abstract] [Full Text] [Related]

  • 20. Risk for graft loss in pediatric and young adult kidney transplant recipients due to recurrent IgA nephropathy.
    Engen RM, Bartosh SM, Smith JM, Perkins JD, Harshman LA.
    Am J Transplant; 2024 Jan 27; 24(1):37-45. PubMed ID: 37595842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.